Archives for March 21, 2023

← 2023

BioNTech and OncoC4 team up on novel checkpoint antibody

21-Mar-2023

By Rachel Arthur

BioNTech and OncoC4 have announced a worldwide license and collaboration agreement to develop and commercialize OncoC4’s next-generation anti-CTLA-4 monoclonal antibody candidate, ONC-392, as monotherapy or combination therapy in various cancer...

Vaccitech reports positive interim data in study on immunotherapeutic for HPV infection

21-Mar-2023

By Jane Byrne

Oxford UK based Vaccitech reports positive topline interim data from a Phase 1b/2 clinical trial of VTP-200 in women with low-grade cervical human papillomavirus (HPV) lesions.

Novartis and Biogen exit deals with Sangamo

21-Mar-2023

By Jane Byrne

Both Novartis and Biogen have terminated partnerships with Sangamo Therapeutics in the past week.